GGD Amsterdam

Research site

The Netherlands Nieuwe Achtergracht 100, 1018 WT Amsterdam, The Netherlands

1 trial recruiting
Monkeypox · Monkeypox immunisation · Papilloma viral infection
Adult patients

About Specializations

GGD Amsterdam in Amsterdam, The Netherlands specialises in clinical trials of conditions such as Monkeypox, Monkeypox immunisation, Papilloma viral infection, and other specialisations. This site conducts important research.

Main research areas of the site

Virus Diseases at GGD Amsterdam

Research at this site focuses on viral infectious diseases, especially HPV infection and mpox. The trials are designed to better understand how vaccination can protect people against these infections and to evaluate whether vaccine responses remain strong with different vaccination approaches.

Studying protection against mpox through booster vaccination research
Evaluating the effectiveness of the HPV vaccine in preventing infection
Assessing vaccine-induced immune response in healthy participants and at-risk groups

At the Department of CSGA in Amsterdam, this work supports public health by testing whether vaccination strategies can improve prevention and strengthen protection against important virus diseases.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

Nieuwe Achtergracht 1001018 WT AmsterdamThe Netherlands

Open in maps ↗

Recruiting now: 1 trial
Conditions studied: 3

More sites in Amsterdam The Netherlands

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Quick filters

2 clinical trials

Monkeypox+1

Recruiting

Study of Different Doses of MVA-BN Vaccine Booster for Adults with Mpox: Comparing Standard and Reduced Doses

Registered drugNo placebo

Study of Different Doses of MVA-BN Vaccine Booster for Adults with Mpox: Comparing Standard and Reduced Doses

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Modified Vaccinia Ankara – Bavarian Nordic Live Virus
Sponsor:Leids Universitair Medisch Centrum (LUMC)

Contact Research Centre

Papilloma viral infection

Not recruiting

Study on the Effectiveness of the HPV Vaccine in Preventing HPV Infections in Men Who Have Sex with Men Aged 19-26 Using Cervarix

Registered drugNo placebo

Study on the Effectiveness of the HPV Vaccine in Preventing HPV Infections in Men Who Have Sex with Men Aged 19-26 Using Cervarix

Registered drugNo placebo

The Netherlands

Participants:18–64 years · Healthy volunteers
Substances:HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN ADJUVANTED BY AS04 ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED PRODUCED ON BACULOVIRUS HI-5 RIX4446 CELLS, TRICHOPLUSIA NI. DERIVED
Sponsor:Geneeskundige En Gezondheidsdienst Amsterdam

Contact Research Centre

Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites